Table: begin end state 1 20 cytoplasmic 21 42 transmembrane 43 61 non-cytoplasmic 62 83 transmembrane 84 94 cytoplasmic 95 115 transmembrane 116 120 non-cytoplasmic 121 141 transmembrane 142 161 cytoplasmic 162 182 transmembrane 183 202 non-cytoplasmic 203 222 transmembrane 223 270 cytoplasmic 271 291 transmembrane 292 315 non-cytoplasmic 316 337 transmembrane 338 343 cytoplasmic 344 360 transmembrane 361 365 non-cytoplasmic 366 387 transmembrane 388 398 cytoplasmic 399 422 transmembrane 423 433 non-cytoplasmic 434 453 transmembrane 454 472 cytoplasmic
Input: >WP_103231791.1 NCBI__GCF_002899945.2:WP_103231791.1 MAEMAGKYDKGVLGRRKKPNLSMLQIINMSMGFLGIQMAFGLQNGNASRILGNLGADVHE LSWFWLVAPVTGLIVQPIIGHMGDNTWSPLGRRKPYFLIGAVLCAVGLVLLPNAASVTQM FAANALLLAVIFLAMMDASVNIAMEPFRALVGDMLPKHQGTIGFSVQTILIGIGAVLGSY LPDWLTKIGISNEAPQGFVADNVIYSFYIGAGLLIISILYTIMTTREYSPQEFAEFEDEK EAEKHESKFSDIFKDFASIPVQMKKLGIVQFFSWFALFTMWVFTTSALATHHLGLSPEDT HSKAFNDAGDLTGKLFGMYNLWAIPFAFLLTPIAKLIGKKQTHALALLCGGLGLISMYFI KEVDHLWISMIGLGFAWASILAMPYAMLIDVIPQRKMGVYMGIFNFFIVIPQIINGLFGG PIVSGIFGKQAMDYVVVGGVCMLIGAVVTMIFVKSEDETPKEIEDEIKQVHF
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server